Page 506 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

484 PART IV Specific Malignancies in the Small Animal Patient

307. Cribb AE: Feline gastrointestinal adenocarcinoma: a review and 330. Pohlman LM, Higginbotham ML, Welles EG, et al.: Immunophe-
retrospective study, Can Vet J 29:709, 1988. notypic and histologic classification of 50 cases of feline gastroin-
308. Bonfanti U, Bertazzolo W, Bottero E, et al.: Diagnostic value of cyto- testinal lymphoma, Vet Pathol 46:259–268, 2009.
VetBooks.ir logic examination of gastrointestinal tract tumors in dogs and cats: 83 331. Yamada K, Morimoto M, Kishimoto M, et al.: Virtual endos-
copy of dogs using multi‐detector row CT, Vet Radiol Ultrasound
cases (2001-2004), J Am Vet Med Assoc 229:1130–1133, 2006.
48:318–322, 2007.
309. Dennis MM, Bennett N, Ehrhart EJ: Gastric adenocarcinoma
and chronic gastritis in two related Persian cats, Vet Pathol 43: 332. Hoey S, Drees R, Hetzel S: Evaluation of the gastrointestinal tract
358–362, 2006. in dogs using computed tomography, Vet Radiol Ultrasound 54:
310. Bridgeford EC, Marini RP, Feng Y, et al.: Gastric Helicobacter spe- 25–30, 2013.
cies as a cause of feline gastric lymphoma: a viable hypothesis, Vet 333. Fitzgerald E, Lam R, Drees R: Improving conspicuity of the canine
Immunol Immunopathol 123:106–113, 2008. gastrointestinal wall using dual phase contrast-enhanced computed
311. Barrett LE, Skorupski K, Brown DC, et al.: Outcome following tomography: a retrospective cross-sectional study, Vet Radiol Ultra-
treatment of feline gastrointestinal mast cell tumours, Vet Comp sound 58:151–162, 2017.
Oncol 16:188–193, 2018. 334. Lamb CR, Grierson J: Ultrasonographic appearance of primary
312. Rossmeisl JH, Forrester SD, Robertson JL, et al.: Chronic vomiting gastric neoplasia in 21 dogs, J Small Anim Pract 40:211–215, 1999.
associated with a gastric carcinoid in a cat, J Am Anim Hosp Assoc 335. Marolf AJ, Bachand AM, Sharber J, et al.: Comparison of endos-
38:61–66, 2002. copy and sonography findings in dogs and cats with histologically
313. Smith TJ, Baltzer WI, Ruaux CG, et al.: Gastric smooth muscle confirmed gastric neoplasia, J Small Anim Pract 56:339–344, 2015.
hamartoma in a cat, J Feline Med Surg 12:334–337, 2010. 336. Willard MD, Mansell J, Fosgate GT, et al.: Effect of sample quality
314. Daure E, Jania R, Jennings S, et al.: Ultrasonographic and clini- on the sensitivity of endoscopic biopsy for detecting gastric and duo-
copathological features of pyloroduodenal adenomatous polyps in denal lesions in dogs and cats, J Vet Intern Med 22:1084–1089, 2008.
cats, J Feline Med Surg 19:141–145, 2017. 337. Riondato F, Miniscalco B, Berio E, et al.: Diagnosis of canine
315. Lauren P: The two histological main types of gastric carcinoma: dif- gastric adenocarcinoma using squash preparation cytology, Vet J
fuse and so-called intestinal-type carcinoma. An attempt at a histo- 201:390–394, 2014.
clinical classification, Acta Pathol Microbiol Scand 64:31–49, 1965. 338. Eisele J, McClaran JK, Runge JJ, et al.: Evaluation of risk factors
316. Wadhwa R, Song S, Lee J-S, et al.: Gastric cancer-molecular and for morbidity and mortality after pylorectomy and gastroduode-
clinical dimensions, Nat Rev Clin Oncol 10:643–655, 2013. nostomy in dogs, Vet Surg 39:261–267, 2010.
317. Pollock S, Wagner BM: Gastric adenocarcinoma or linitis plastica 339. Beaumont PR: Anastomotic jejunal ulcer secondary to gastrojeju-
in a dog, Vet Med Small Anim Clin 68:139–142, 1973. nostomy in a dog, J Am Anim Hosp Assoc 17:233–237, 1981.
318. Kapatkin AS, Mullen HS, Matthiesen DT, et al.: Leiomyosar- 340. Macdonald JS, Smalley SR, Benedetti J, et al.: Chemoradiotherapy
coma in dogs: 44 cases (1983-1988), J Am Vet Med Assoc 201: after surgery compared with surgery alone for adenocarcinoma of
1077–1079, 1992. the stomach or gastroesophageal junction, N Engl J Med 345:725–
319. Kerpsack SJ, Birchard SJ: Removal of leiomyomas and other nonin- 730, 2001.
vasive masses from the cardiac region of the canine stomach, J Am 341. Terragni R, Casadei Gardini A, Sabattini S, et al.: EGFR, HER-2
Anim Hosp Assoc 30:500–504, 1994. and KRAS in canine gastric epithelial tumors: a potential human
320. Beaudry D, Knapp DW, Montgomery T, et al.: Hypoglycemia in model? PLoS One 9:e85388, 2014.
four dogs with smooth muscle tumors, J Vet Intern Med 9:415–418, 342. Sellon RK, Bissonnette K, Bunch SE: Long-term survival after total
1995. gastrectomy for gastric adenocarcinoma in a dog, J Vet Intern Med
321. Bagley RS, Levy JK, Malarkey DE: Hypoglycemia associated with 10:333–335, 1996.
intra-abdominal leiomyoma and leiomyosarcoma in six dogs, J Am 343. Walter MC, Matthiesen DT, Stone EA: Pylorectomy and gastrodu-
Vet Med Assoc 208:69–71, 1996. odenostomy in the dog: technique and clinical results in 28 cases,
322. Gillespie V, Baer K, Farrelly J, et al.: Canine gastrointestinal stro- J Am Vet Med Assoc 187:909–914, 1985.
mal tumors: immunohistochemical expression of CD34 and exam- 344. Beck JA, Simpson DS: Surgical treatment of gastric leiomyoma in
ination of prognostic indicators including proliferation markers a dog, Aust Vet J 77:161–163, 1999.
Ki67 and AgNOR, Vet Pathol 48:283–291, 2011. 345. Torre LA, Bray F, Siegel RL, et al.: Global cancer statistics, 2012,
323. Sircar K, Hewlett BR, Huizinga JD, et al.: Interstitial cells of Cajal CA Cancer J Clin 65:87–108, 2015.
as precursors of gastrointestinal stromal tumors, Am J Surg Pathol 346. Torre LA, Siegel RL, Ward EM, et al.: Global cancer incidence and
23:377–389, 1999. mortality rates and trends—an update, Cancer Epidemiol Biomark-
324. Kobayashi M, Kuroki S, Ito K, et al.: Imatinib-associated tumour ers Prev 25:16–27, 2016.
response in a dog with a non-resectable gastrointestinal stro- 347. Plummer M, Franceschi S, Vignat J, et al.: Global burden of gastric
mal tumour harbouring a c-kit exon 11 deletion mutation, Vet J cancer attributable to Helicobacter pylori, Int J Cancer 136:487–
198:271–274, 2013. 490, 2015.
325. Irie M, Takeuchi Y, Ohtake Y, et al.: Imatinib mesylate treatment 348. Guggenheim DE, Shah MA: Gastric cancer epidemiology and risk
in a dog with gastrointestinal stromal tumors with a c-kit mutation, factors, J Surg Oncol 107:230–236, 2012.
J Vet Med Sci 77:1535–1539, 2015. 349. Gotoda T, Iwasaki M, Kusano C, et al.: Endoscopic resection of
326. Takanosu M, Amano S, Kagawa Y: Analysis of c-KIT exon 11 early gastric cancer treated by guideline and expanded National
mutations in canine gastrointestinal stromal tumours, Vet J Cancer Centre criteria, Br J Surg 97:868–871, 2010.
207:118–123, 2016. 350. Halabi El HM, Lawrence W: Clinical results of various recon-
327. Gregory-Bryson E, Bartlett E, Kiupel M, et al.: Canine and human structions employed after total gastrectomy, J Surg Oncol 97:
gastrointestinal stromal tumors display similar mutations in c-KIT 186–192, 2008.
exon 11, BMC Cancer 10:559, 2010. 351. Ku GY, Ilson DH: Neoadjuvant and adjuvant treatment—strate-
328. Morini M, Gentilini F, Pietra M, et al.: Cytological, immunohisto- gies and clinical trials—Western perspective. In Strong VE, editor:
chemical and mutational analysis of a gastric gastrointestinal stro- Gastric cancer, ed 1, New York, 2015, Springer, pp 297–302.
mal tumour in a cat, J Comp Pathol 145:152–157, 2011. 352. Bang Y-J, Van Cutsem E, Feyereislova A, et al.: Trastuzumab in
329. Finotello R, Vasconi ME, Sabattini S, et al.: Feline large granu- combination with chemotherapy versus chemotherapy alone for
lar lymphocyte lymphoma: an Italian Society of Veterinary treatment of HER2-positive advanced gastric or gastro-oesophageal
Oncology (SIONCOV) retrospective study, Vet Comp Oncol 16: junction cancer (ToGA): a phase 3, open-label, randomised con-
159–166, 2018. trolled trial, Lancet 376:687–697, 2010.